Showing results (161-170 of 175) with videos related to
Sort By:
Pageof 18
Journal of Alzheimer'S Disease : JAD|April 18, 2022
Prevalence and Safety of COVID-19 Vaccination in Community-Dwelling People with Dementia: Findings from a Tertiary Memory Clinic in ItalyMartina Valletta, Marco Canevelli, Fabrizia D'Antonio, et al.Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|June 1, 2021
Management of bone fragility in type 2 diabetes: Perspective from an interdisciplinary expert panelIacopo Chiodini, Agostino Gaudio, Andrea Palermo, et al.Clinical Journal of the American Society of Nephrology : CJASN|February 18, 2026
Kidney and Survival Outcomes with Semaglutide by Chronic Kidney Disease Severity in the FLOW TrialKatherine R Tuttle, Johannes F E Mann, Manuel M Mayrdorfer, et al.Diabetes/Metabolism Research and Reviews|March 7, 2023
Association of osteocalcin, osteoprotegerin, and osteopontin with cardiovascular disease and retinopathy in type 2 diabetesErnesto Maddaloni, Lucia Coraggio, Rocco Amendolara, et al.Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|November 1, 2025
The Caregiver Burden in Patients with Chronic Disorders of Consciousness: Differences Between Long-Term Tele-Assistance System and In-Hospital Care FacilitiesMarianna Contrada, Ivan Giuseppe Cammarata, Federica Scarfone, et al.The British Journal of Nutrition|December 3, 2011
Dietary factors and low-grade inflammation in relation to overweight and obesityPhilip C Calder, Namanjeet Ahluwalia, Fred Brouns, et al.NPJ Precision Oncology|February 1, 2024
Autologous anti-GD2 CAR T cells efficiently target primary human glioblastomaChiara Chiavelli, Malvina Prapa, Giulia Rovesti, et al.European Heart Journal|August 30, 2024
Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trialKenneth W Mahaffey, Katherine R Tuttle, Mustafa Arici, et al.Journal of the American Society of Nephrology : JASN|November 14, 2018
The Long-Term Impact of Renin-Angiotensin System (RAS) Inhibition on Cardiorenal Outcomes (LIRICO): A Randomized, Controlled TrialValeria Saglimbene, Suetonia C Palmer, Marinella Ruospo, et al.Cancer Management and Research|May 24, 2019
Immune inflammation indicators in anal cancer patients treated with concurrent chemoradiation: training and validation cohort with online calculator (ARC: Anal Cancer Response Classifier)Andrea Casadei-Gardini, Francesco Montagnani, Chiara Casadei, et al.Pageof 18